{
    "2018-12-27": [
        [
            {
                "time": "",
                "original_text": "华大基因成近期增持最多的上市公司 董事长汪建增持比例最高",
                "features": {
                    "keywords": [
                        "华大基因",
                        "董事长",
                        "汪建",
                        "增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "管理层坚定看好华大基因 汪建等人1.5亿元增持计划完成过半",
                "features": {
                    "keywords": [
                        "管理层",
                        "华大基因",
                        "汪建",
                        "增持计划"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华大基因完成云南省首个无创高通量基因检测实验室建设",
                "features": {
                    "keywords": [
                        "华大基因",
                        "无创高通量基因检测",
                        "实验室建设"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "多家公司大股东增持",
                "features": {
                    "keywords": [
                        "大股东",
                        "增持"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}